Differential inhibition of hepatic microsomal alkoxyresorufin O-dealkylation activities by tetrachlorobiphenyls

Chemico-Biological Interactions

Volumn 169, Issue 1, 2007, Pages 42-52

  Edwards, Patrick R ^a   Hrycay, Eugene G ^a   Bandiera, Stelvio M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alkoxyresorufin O dealkylation; Cytochrome P450; Immunoblot analysis; Tetrachlorobiphenyls

Indexed keywords

2,2',4,4' TETRACHLOROBIPHENYL; 2,2',5,5' TETRACHLOROBIPHENYL; 3 METHYLCHOLANTHRENE; 3,3',4,4' TETRACHLOROBIPHENYL; BENZYLOXYRESORUFIN O DEALKYLASE; ETHOXYRESORUFIN DEETHYLASE; LIVER ENZYME; METHOXYRESORUFIN O DEALKYLASE; PHENOBARBITAL; POLYCHLORINATED BIPHENYL DERIVATIVE; RESORUFIN DERIVATIVE; TETRACHLOROBIPHENYL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHLORINATION; CONTROLLED STUDY; DEALKYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; IN VITRO STUDY; LIVER MICROSOME; MALE; NONHUMAN; POLLUTANT; RAT;

ALKYLATION; ANIMALS; CYTOCHROME REDUCTASES; MALE; MICROSOMES, LIVER; MODELS, MOLECULAR; OXAZINES; POLYCHLORINATED BIPHENYLS; RATS;

ANIMALIA; RATTUS; ZEA MAYS;

EID: 34447250786     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.05.004     Document Type: Article

References (32)

1. Bandiera S.M. Cytochrome P450 enzymes as biomarkers of PCB exposure and modulators of toxicity. In: Robertson L.W., and Hansen L.G. (Eds). PCBs: Recent Advances in Environmental Toxicology and Health Effects (2001), University Press of Kentucky, Lexington, KY 185-192
2. Haraguchi K., Kato Y., Koga N., and Degawa M. Metabolism of polychlorinated biphenyls by Gunn rats: identification and serum retention of catechol metabolites. Chem. Res. Toxicol. 17 (2004) 1684-1691
3. Borlakoglu J.T., Drew M.G., Wilkins J.P., and Dils R.R. Effects of molecular substitution patterns on the cytochrome P-450-dependent metabolism of 2,2′,3,5,5′,6- and 2,2′,3,4,4′,6-hexachlorobiphenyl by rat liver microsomal monooxygenases. Biochim. Biophys. Acta 1036 (1990) 167-175
4. Borlakoglu J.T., and Wilkins J.P. Metabolism of di-, tri-, tetra-, penta- and hexachlorobiphenyls by hepatic microsomes isolated from control animals and animals treated with Aroclor 1254, a commercial mixture of polychlorinated biphenyls (PCBs). Comp. Biochem. Physiol. C 105 (1993) 95-106
5. Ishida C., Koga N., Hanioka N., Saeki H.K., and Yoshimura H. Metabolism in vitro of 3,4,3′,4′- and 2,5,2′,5′-tetrachlorobiphenyl by rat liver microsomes and highly purified cytochrome P-450. J. Pharmacobiodyn. 14 (1991) 276-284
6. Nerurkar P.V., Park S.S., Thomas P.E., Nims R.W., and Lubet R.A. Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse. Biochem. Pharmacol. 46 (1993) 933-943
7. Parkinson A., Safe S.H., Robertson L.W., Thomas P.E., Ryan D.E., Reik L.M., and Levin W. Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in liver microsomes from polychlorinated or polybrominated biphenyl-treated rats. A study of structure-activity relationships. J. Biol. Chem. 258 (1983) 5967-5976
8. Burke M.D., and Mayer R.T. Differential effects of phenobarbitone and 3-methylcholanthrene induction on the hepatic microsomal metabolism and cytochrome P-450-binding of phenoxazone and a homologous series of its n-alkyl ethers (alkoxyresorufins). Chem. Biol. Interact. 45 (1983) 243-258
9. Ikegwuonu F.I., Ganem L.G., Larson M.C., Shen X., and Jefcoate C.R. The regulation by gender, strain, dose, and feeding status of the induction of multiple forms of cytochrome P450 isozymes in rat hepatic microsomes by 2,4,5,2′,4′,5′-hexachlorobiphenyl. Toxicol. Appl. Pharmacol. 139 (1996) 33-41
10. Li M., and Hansen L.G. Responses of prepubertal female rats to environmental PCBs with high and low dioxin equivalencies. Fundam. Appl. Toxicol. 33 (1996) 282-293
11. Chen J.J., Chen G.S., and Bunce N.J. Inhibition of CYP 1A2-dependent MROD activity in rat liver microsomes: an explanation of the hepatic sequestration of a limited subset of halogenated aromatic hydrocarbons. Environ. Toxicol. 18 (2003) 115-119
12. Petrulis J.R., and Bunce N.J. Competitive inhibition by inducer as a confounding factor in the use of the ethoxyresorufin-O-deethylase (EROD) assay to estimate exposure to dioxin-like compounds. Toxicol. Lett. 105 (1999) 251-260
13. Petrulis J.R., Chen G., Benn S., LaMarre J., and Bunce N.J. Application of the ethoxyresorufin-O-deethylase (EROD) assay to mixtures of halogenated aromatic compounds. Environ. Toxicol. 16 (2001) 177-184
14. Staskal D.F., Diliberto J.J., Devito M.J., and Birnbaum L.S. Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. Toxicol. Sci. 84 (2005) 225-231
15. Hrycay E.G., and Bandiera S.M. Spectral interactions of tetrachlorobiphenyls with hepatic microsomal cytochrome P450 enzymes. Chem. Biol. Interact. 146 (2003) 285-296
16. ® on hepatic expression of cytochrome P450 2B in rats. Biochem. Pharmacol. 52 (1996) 735-742
17. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
18. Omura T., and Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239 (1964) 2370-2378
19. Burke M.D., and Mayer R.T. Ethoxyresorufin: direct fluorimetric assay of a microsomal O-dealkylation which is preferentially inducible by 3-methylcholanthrene. Drug Metab. Dispos. 2 (1974) 583-588
20. Strobel H.W., and Dignam J.D. Purification and properties of NADPH-cytochrome P-450 reductase. Meth. Enzymol. 52 (1978) 89-96
21. Ryan D.E., and Levin W. Purification and characterization of hepatic microsomal cytochrome P-450. Pharmacol. Ther. 45 (1990) 153-239
22. Cooper K.O., Reik L.M., Jayyosi Z., Bandiera S., Kelley M., Ryan D.E., Daniel R., McCluskey S.A., Levin W., and Thomas P.E. Regulation of two members of the steroid-inducible cytochrome P450 subfamily (3A) in rats. Arch. Biochem. Biophys. 301 (1993) 345-354
23. Jan Y.-H., Mishin V., Busch C.M., and Thomas P.E. Generation of specific antibodies and their use to characterize sex differences in four rat P450 3A enzymes following vehicle and pregnenolone 16α-carbonitrile treatment. Arch. Biochem. Biophys. 446 (2006) 101-110
24. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparanta T., and Mayer R.T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34 (1985) 3337-3345
25. Koga N., Kikuichi-Nishimura N., and Yoshimura H. Effect of cytochrome P450 inducers on liver microsomal metabolism of tetrachlorobiphenyls in rats, guinea pigs and hamsters. Biol. Pharm. Bull. 18 (1995) 705-710
26. Schlezinger J.J., White R.D., and Stegeman J.J. Oxidative inactivation of cytochrome P-450 1A (CYP1A) stimulated by 3,3′,4,4′-tetrachlorobiphenyl: production of reactive oxygen by vertebrate CYP1As. Mol. Pharmacol. 56 (1999) 588-597
27. Besselink H.T., Denison M.S., Hahn M.E., Karchner S.I., Vethaak A.D., Koeman J.H., and Brouwer A. Low inducibility of CYP1A activity by polychlorinated biphenyls (PCBs) in flounder (Platichthys flesus): characterization of the Ah receptor and the role of CYP1A inhibition. Toxicol. Sci. 43 (1998) 161-171
28. Fischer L.J., Seegal R.F., Ganey P.E., Pessah I.N., and Kodavanti P.R. Symposium overview: toxicity of non-coplanar PCBs. Toxicol. Sci. 41 (1998) 49-61
29. Safe S., Bandiera S., Sawyer T., Robertson L., Safe L., Parkinson A., Thomas P.E., Ryan D.E., Reik L.M., and Levin W. PCBs: structure-function relationships and mechanism of action. Environ. Health Perspect. 60 (1985) 47-56
30. Matthews H.B., and Dedrick R.L. Pharmacokinetics of PCBs. Annu. Rev. Pharmacol. Toxicol. 24 (1984) 85-103
31. DeVoss J.J., Sibbesen O., Zhang Z., and Ortiz de Montellano P.R. Substrate docking algorithms and prediction of the substrate specificity of cytochrome P450cam and its L244A mutant. J. Am. Chem. Soc. 119 (1997) 5480-5498
32. Lewis D.F.V. Cytochromes P450: Structure, Function and Mechanism (1996), Taylor and Francis, London, UK